Colinz Laboratories Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Colinz Laboratories Ltd is ₹ 45.06 as of 18 May 15:30 . The p/e ratio of Colinz Laboratories Ltd changed from 36.8 to 19.5 over 5 quarters. This represents a CAGR of -39.83% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The market cap of Colinz Laboratories Ltd changed from ₹ 33.11 crore to ₹ 17.16 crore over 5 quarters. This represents a CAGR of -40.89% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The revenue of Colinz Laboratories Ltd for the Mar '26 is ₹ 1.92 crore as compare to the Dec '25 revenue of ₹ 1.51 crore. This represent the growth of 27.15% The revenue of Procter & Gamble Health Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 378.22 crore. This represent the decline of -100% The ebitda of Colinz Laboratories Ltd for the Mar '26 is ₹ 0.27 crore as compare to the Dec '25 ebitda of ₹ 0.18 crore. This represent the growth of 50% The ebitda of Procter & Gamble Health Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 114.82 crore. This represent the decline of -100% The net profit of Colinz Laboratories Ltd changed from ₹ 0.05 crore to ₹ 0.17 crore over 8 quarters. This represents a CAGR of 84.39% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The dividend payout of Colinz Laboratories Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Colinz Laboratories Ltd

Colinz Laboratories Limited, was incorporated as a Private Limited Company in 1986.
The Company got converted into Public Limited Company in 1995, which however started their manufacturing and marketing activities in 1995.
The Company manufactures a wide variety of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams etc.
The Company is having certain specialized products for Gynaecology, Cardiology, Gastroentrology etc.
Since, the Company falls under the MSME sector, it established reputation as a quality supplier of medicines in the domestic market, wherever the Company has operation. Apart from this, the Company has a WHO compliant plant at Sinnar.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Colinz Laboratories Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Colinz Laboratories Ltd or Procter & Gamble Health Ltd?

Market cap of Colinz Laboratories Ltd is 5 Cr while Market cap of Procter & Gamble Health Ltd is 8,775 Cr

What are the key factors driving the stock performance of Colinz Laboratories Ltd and Procter & Gamble Health Ltd?

The stock performance of Colinz Laboratories Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Colinz Laboratories Ltd and Procter & Gamble Health Ltd?

As of May 18, 2026, the Colinz Laboratories Ltd stock price is INR ₹45.05. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5286.55.

How do dividend payouts of Colinz Laboratories Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Colinz Laboratories Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.